Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Wyszukujesz frazę ""Webb, Gabriela M"" wg kryterium: Autor


Wyświetlanie 1-1 z 1
Tytuł:
Suppression of human and simian immunodeficiency virus replication with the CCR5-specific antibody Leronlimab in two species.
Autorzy:
Chang XL; Vaccine & Gene Therapy Institute, Oregon Health & Science University, Portland, Oregon, United States of America.; Oregon National Primate Research Center, Oregon Health & Science University, Portland, Oregon, United States of America.
Reed JS; Vaccine & Gene Therapy Institute, Oregon Health & Science University, Portland, Oregon, United States of America.
Webb GM; Vaccine & Gene Therapy Institute, Oregon Health & Science University, Portland, Oregon, United States of America.
Wu HL; Vaccine & Gene Therapy Institute, Oregon Health & Science University, Portland, Oregon, United States of America.
Le J; Quest Clinical Research, San Francisco, California, United States of America.
Bateman KB; Vaccine & Gene Therapy Institute, Oregon Health & Science University, Portland, Oregon, United States of America.
Greene JM; Vaccine & Gene Therapy Institute, Oregon Health & Science University, Portland, Oregon, United States of America.
Pessoa C; Vaccine & Gene Therapy Institute, Oregon Health & Science University, Portland, Oregon, United States of America.
Waytashek C; Vaccine & Gene Therapy Institute, Oregon Health & Science University, Portland, Oregon, United States of America.
Weber WC; Vaccine & Gene Therapy Institute, Oregon Health & Science University, Portland, Oregon, United States of America.
Hwang J; Vaccine & Gene Therapy Institute, Oregon Health & Science University, Portland, Oregon, United States of America.
Fischer M; Oregon National Primate Research Center, Oregon Health & Science University, Portland, Oregon, United States of America.
Moats C; Oregon National Primate Research Center, Oregon Health & Science University, Portland, Oregon, United States of America.
Shiel O; Oregon National Primate Research Center, Oregon Health & Science University, Portland, Oregon, United States of America.
Bochart RM; Oregon National Primate Research Center, Oregon Health & Science University, Portland, Oregon, United States of America.
Crank H; Oregon National Primate Research Center, Oregon Health & Science University, Portland, Oregon, United States of America.
Siess D; Oregon National Primate Research Center, Oregon Health & Science University, Portland, Oregon, United States of America.
Giobbi T; Oregon National Primate Research Center, Oregon Health & Science University, Portland, Oregon, United States of America.
Torgerson J; Oregon National Primate Research Center, Oregon Health & Science University, Portland, Oregon, United States of America.
Agnor R; Oregon National Primate Research Center, Oregon Health & Science University, Portland, Oregon, United States of America.
Gao L; Oregon National Primate Research Center, Oregon Health & Science University, Portland, Oregon, United States of America.
Dhody K; Amarex Clinical Research LLC, Germantown, Maryland, United States of America.
Lalezari JP; Quest Clinical Research, San Francisco, California, United States of America.
Bandar IS; Department of Medicine, Division of Infectious Diseases, Weill Cornell Medicine, New York, New York, United States of America.
Carnate AM; Department of Medicine, Division of Infectious Diseases, Weill Cornell Medicine, New York, New York, United States of America.
Pang AS; Department of Medicine, Division of Infectious Diseases, Weill Cornell Medicine, New York, New York, United States of America.
Corley MJ; Department of Medicine, Division of Infectious Diseases, Weill Cornell Medicine, New York, New York, United States of America.
Kelly S; CytoDyn Inc., Vancouver, Washington, United States of America.
Pourhassan N; CytoDyn Inc., Vancouver, Washington, United States of America.
Smedley J; Oregon National Primate Research Center, Oregon Health & Science University, Portland, Oregon, United States of America.
Bimber BN; Vaccine & Gene Therapy Institute, Oregon Health & Science University, Portland, Oregon, United States of America.; Oregon National Primate Research Center, Oregon Health & Science University, Portland, Oregon, United States of America.
Hansen SG; Vaccine & Gene Therapy Institute, Oregon Health & Science University, Portland, Oregon, United States of America.
Ndhlovu LC; Department of Medicine, Division of Infectious Diseases, Weill Cornell Medicine, New York, New York, United States of America.
Sacha JB; Vaccine & Gene Therapy Institute, Oregon Health & Science University, Portland, Oregon, United States of America.; Oregon National Primate Research Center, Oregon Health & Science University, Portland, Oregon, United States of America.
Pokaż więcej
Źródło:
PLoS pathogens [PLoS Pathog] 2022 Mar 31; Vol. 18 (3), pp. e1010396. Date of Electronic Publication: 2022 Mar 31 (Print Publication: 2022).
Typ publikacji:
Clinical Study; Journal Article
MeSH Terms:
Simian Immunodeficiency Virus*
Animals ; Antibodies, Monoclonal, Humanized/pharmacology ; HIV Antibodies ; Humans ; Macaca mulatta ; Receptors, CCR5
Czasopismo naukowe
    Wyświetlanie 1-1 z 1

    Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies